USPTO serial 76243563
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Laboratoires De Biologie Vegetale Yves Rocher
56200 La Gacilly, FR
Other trademarks owned by Laboratoires De Biologie Vegetale Yves Rocher
Laboratoires De Biologie Vegetale Yves Rocher
56200 La Gacilly, FR
Other trademarks owned by Laboratoires De Biologie Vegetale Yves Rocher
Laboratoires De Biologie Vegetale Yves Rocher
56200 La Gacilly, FR
Other trademarks owned by Laboratoires De Biologie Vegetale Yves Rocher
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Herbert H. Finn
HERBERT H FINN GREENBERG TRAURIG, PC77 W WACKER DR STE 2500CHICAGO, IL 60601UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 003 | essential oils for personal use, namely perfumed oils and aromatherarpy oils | SECTION 8 - CANCELLED | Apr 10, 2003 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2011 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Mar 1, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 22, 2004 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Nov 19, 2004 | ALIE | ASSIGNED TO LIE | — |
| Nov 17, 2004 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 16, 2004 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 18, 2004 | PAPER RECEIVED | — | |
| Oct 15, 2004 | IUAF | USE AMENDMENT FILED | — |
| Apr 29, 2004 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 27, 2004 | CFIT | CASE FILE IN TICRS | — |
| Apr 19, 2004 | PAPER RECEIVED | — | |
| Apr 15, 2004 | EXT3 | SOU EXTENSION 3 FILED | — |
| Nov 18, 2003 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 22, 2003 | PAPER RECEIVED | — | |
| Oct 15, 2003 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 4, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 18, 2003 | PAPER RECEIVED | — | |
| Apr 15, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 15, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 23, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 23, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 3, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 25, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 27, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2001 | DOCK | ASSIGNED TO EXAMINER | — |